Literature DB >> 31273033

Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.

Yang Tian1,2,3, Chunying Wang1,2,3, Shuohua Chen1,2,3, Jie Liu1,2,3, Yan Fu1,2,3, Yongzhang Luo4,2,3.   

Abstract

Extracellular heat shock protein 90 alpha (eHsp90α, also known as HSP90AA1) has been widely reported to promote tumor cell motility and tumor metastasis in various types of cancer. Several extracellular proteins and membrane receptors have been identified as interacting proteins of eHsp90α and mediate its pro-metastasis function. However, the regulatory mechanism of eHsp90α activity remains largely unknown. Here, we report that clusterin, a protein newly demonstrated to interact with eHsp90α, modulates eHsp90α signaling. We found that clusterin potentiated the effects of eHsp90α on activation of the AKT, ERK and NF-κB protein families, epithelial-to-mesenchymal transition (EMT) and migration in breast cancer cells. Furthermore, in vivo investigations demonstrated similar synergistic effects of eHsp90α and clusterin on tumor metastasis. Notably, the effects of eHsp90α and clusterin were mediated by low-density lipoprotein receptor-related protein 1 (LRP1). Proximity ligation assay and co-immunoprecipitation experiments demonstrated that clusterin participated in eHsp90α-LRP1 complex formation, which enhanced the binding affinity of eHsp90α to LRP1. Collectively, our data establish a role of clusterin as a newly discovered modulator of eHsp90α, and unravel detailed molecular mechanisms underlying the synergistic metastasis-promoting effects of clusterin and eHsp90α.
© 2019. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Clusterin; EMT; HSP90AA1; LRP1; Metastasis; eHsp90α

Mesh:

Substances:

Year:  2019        PMID: 31273033     DOI: 10.1242/jcs.228213

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer.

Authors:  Baoyue Huang; Jinmiao Pan; Haizhou Liu; Yamei Tang; Shirong Li; Yingzhen Bian; Shufang Ning; Jilin Li; Litu Zhang
Journal:  Front Mol Biosci       Date:  2022-07-11

Review 2.  The role and function of CLU in cancer biology and therapy.

Authors:  Yefei Zhang; Xiang Lv; Liming Chen; Yan Liu
Journal:  Clin Exp Med       Date:  2022-09-13       Impact factor: 5.057

3.  Extracellular Hsp90α Supports the ePKM2-GRP78-AKT Axis to Promote Tumor Metastasis.

Authors:  Shaosen Zhang; Caihong Wang; Jiujun Ju; Caixia Wang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

4.  Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis.

Authors:  Haizhou Liu; Zihan Zhang; Yi Huang; Wene Wei; Shufang Ning; Jilin Li; Xinqiang Liang; Kaisheng Liu; Litu Zhang
Journal:  Front Cell Dev Biol       Date:  2021-05-24

5.  A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.

Authors:  Yingli Zhang; Xiaoliang Shi; Jiejie Zhang; Xi Chen; Peng Zhang; Angen Liu; Tao Zhu
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

6.  Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration.

Authors:  Fabrizio Di Giuseppe; Marzia Carluccio; Mariachiara Zuccarini; Patricia Giuliani; Lucia Ricci-Vitiani; Roberto Pallini; Paolo De Sanctis; Roberta Di Pietro; Renata Ciccarelli; Stefania Angelucci
Journal:  Biomedicines       Date:  2021-02-03

7.  Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy.

Authors:  Shubin Chen; Qitao Yu; Shaozhang Zhou
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

8.  An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer.

Authors:  Jing Yuan; Fangfang Duan; Wenyu Zhai; Chenge Song; Li Wang; Wen Xia; Xin Hua; Zhongyu Yuan; Xiwen Bi; Jiajia Huang
Journal:  Int J Womens Health       Date:  2021-11-03

Review 9.  The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review.

Authors:  Juofang Tan; Wei Guo; Su Yang; Dingpei Han; Hecheng Li
Journal:  Transl Lung Cancer Res       Date:  2021-06

10.  Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.

Authors:  Xingyi Guo; Weiqiang Lin; Wanqing Wen; Jeroen Huyghe; Stephanie Bien; Qiuyin Cai; Tabitha Harrison; Zhishan Chen; Conghui Qu; Jiandong Bao; Jirong Long; Yuan Yuan; Fangqin Wang; Mengqiu Bai; Goncalo R Abecasis; Demetrius Albanes; Sonja I Berndt; Stéphane Bézieau; D Timothy Bishop; Hermann Brenner; Stephan Buch; Andrea Burnett-Hartman; Peter T Campbell; Sergi Castellví-Bel; Andrew T Chan; Jenny Chang-Claude; Stephen J Chanock; Sang Hee Cho; David V Conti; Albert de la Chapelle; Edith J M Feskens; Steven J Gallinger; Graham G Giles; Phyllis J Goodman; Andrea Gsur; Mark Guinter; Marc J Gunter; Jochen Hampe; Heather Hampel; Richard B Hayes; Michael Hoffmeister; Ellen Kampman; Hyun Min Kang; Temitope O Keku; Hyeong Rok Kim; Loic Le Marchand; Soo Chin Lee; Christopher I Li; Li Li; Annika Lindblom; Noralane Lindor; Roger L Milne; Victor Moreno; Neil Murphy; Polly A Newcomb; Deborah A Nickerson; Kenneth Offit; Rachel Pearlman; Paul D P Pharoah; Elizabeth A Platz; John D Potter; Gad Rennert; Lori C Sakoda; Clemens Schafmayer; Stephanie L Schmit; Robert E Schoen; Fredrick R Schumacher; Martha L Slattery; Yu-Ru Su; Catherine M Tangen; Cornelia M Ulrich; Franzel J B van Duijnhoven; Bethany Van Guelpen; Kala Visvanathan; Pavel Vodicka; Ludmila Vodickova; Veronika Vymetalkova; Xiaoliang Wang; Emily White; Alicja Wolk; Michael O Woods; Graham Casey; Li Hsu; Mark A Jenkins; Stephen B Gruber; Ulrike Peters; Wei Zheng
Journal:  Gastroenterology       Date:  2020-10-12       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.